Table 1 Basic clinical characteristics of the participants

Age, Mean ± SD

62.9 ± 9.8

63.8 ± 10.4

62.9 ± 9.1

0.309

Sex (M %)

75(56.8%)

46(69.7%)

29 (43.9%)

0.003

HR

76.1 ± 10.6

74.2 ± 9.5

78.0 ± 11.3

0.037

BMI

26.0 ± 4.1

25.4 ± 3.9

26.5 ± 4.4

0.124

Hb

140.5 ± 17.8

141.7 ± 16.0

139.3 ± 19.4

0.456

Hypertension n (%)

82(63.1%)

38(58.5%)

44(67.7%)

0.276

Diabetes mellitus (%)

50 (37.9)

16 (24.2)

34 (51.5)

0.001

eGFR (ml/min/1.73m2)

87.2 (74.0, 99.0)

87.1 (73.0, 99.2)

87.4 (76.4, 98.7)

0.822

TC (mmol/l)

4.0(3.3,5.0)

3.8 (3.0, 4.6)

4.4 (3.6, 5.4)

< 0.001

TG (mmol/l)

1.6 (1.1, 2.2)

1.2 (0.9, 1.4)

2.2 (1.7, 3.2)

< 0.001

HDL.C (mmol/l)

0.9(0.8,1.1)

1.0(0.9,1.2)

0.9(0.8,1.0)

0.005

LDL.C (mmol/l)

2.5(1.8,3.2)

2.5 (1.7, 3.1)

2.5 (1.9, 3.2)

0.296

HbA1c (%)

6.1(5.7,7.4)

5.9(5.7,6.3)

6.9 (5.7, 8.3)

< 0.001

Fasting glucose (mmol/l)

5.9 (5.0, 7.4)

5.2 (4.8, 5.9)

7.0 (5.5, 9.2)

< 0.001

TyG index

9.0 (8.6, 9.4)

8.6 (8.3, 8.8)

9.4 (9.1, 9.8)

< 0.001

GENSINI score

37.0 (23.8, 66.5)

36.5 (21.0, 59.5)

37.5 (25.2, 72.8)

0.340

ACEI/ARB, n (%)

29 (22.0)

14 (21.2)

15 (22.7)

0.833

CCB, n (%)

43 (32.6)

18 (27.3)

25 (37.9)

0.194

Statin, n (%)

0 ( 0.0)

0(0)

0 (0)

1

oral hypoglycemic drugs

17 (12.9)

6 (9.1)

11 (16.7)

0.194

Insulin, n (%)

36 (27.3)

13 (19.7)

23 (34.8)

0.051